Terri Vidals
Terri Vidals
Interview with Medacist President & CEO, David Brzozowski
Interview with Medacist President & CEO, David Brzozowski
Interview with Medacist President & CEO, David Brzozowski
Thursday 24th February 2022
Discover how AI is transforming drug diversion monitoring with Medacist CEO David Brzozowski on 'Drug Diversion Insights'.
26 minutes
Informative
Educational
Engaging
Thought-provoking
Transformative
About this podcast
Author:
Terri Vidals
Overview:
Categories:
Innovative Treatments & Recovery Paths
Nutritional Pathways to Recovery
Family Recovery from Addiction
Navigating Intimate Relationships
Recovery Reimagined
Links:
Visit site
Episodes:
128 (View all)
Do you want to link to this podcast?
Get the buttons here!How AI is Revolutionising Drug Diversion Monitoring: Insights from Medacist CEO David Brzozowski
We're trying to close the whole loop on that whole medication use process, from the time it gets in the door to the time it gets in the central pharmacy and then up to the floor.
Imagine a world where artificial intelligence (AI) is your frontline defense against medication diversion in healthcare. In this episode of 'Drug Diversion Insights', host Terri Vidals chats with David Brzozowski, the President and CEO of Medacist, a company that has been pioneering diversion software surveillance since 1998. Brzozowski shares how Medacist has evolved over the years to offer a cutting-edge diversion monitoring solution, leveraging AI to detect unusual patterns and behaviours among healthcare professionals.
The conversation dives into the nitty-gritty of how AI helps in identifying diversion risks by comparing the behaviours of healthcare workers, auditing data, and reducing false positives. Brzozowski also discusses the collaboration with other companies and the future of diversion monitoring technology. This episode is a must-listen for anyone interested in the intersection of healthcare and technology, offering valuable insights into how AI can help keep patients safe.